Publications by authors named "Fei-Hang Wang"
Purpose: To evaluate the safety and efficacy of I seed strand combined with percutaneous transhepatic biliary drainage (PTBD) and hepatic arterial infusion chemotherapy (HAIC) for unresectable Bismuth-Corlette III and IV stage hilar cholangiocarcinoma (HCCA).
Methods: From January 2018 to December 2021, a total of 128 Bismuth-Corlette III and IV stage HCCA patients with obstructive jaundice were included in this single-center retrospective study. Forty-eight patients underwent I seed strand combined with PTBD and HAIC (group A).
Objective: To explore the value of a new clinical prediction model combined serological indicators and tumor burden score (TBS) in predicting microvascular invasion (MVI) in hepatocellular carcinoma (HCC) patients.
Methods: This study retrospectively analyzed a total of 605 patients who underwent liver tumor resection at our hospital from January 2021 to December 2023. The required clinical data before surgery were collected from the electronic medical record system.
Article Synopsis
- The study aimed to compare the safety and effectiveness of intraluminal brachytherapy using iodine-125 (I) seeds in patients with obstructive jaundice caused by tumor thrombus, focusing on those who had stents placed versus those who did not.
- A total of 42 patients were analyzed; group A received both I seed strands and stents while group B received only I seed strands.
- Results showed that while there was no significant difference in overall survival or jaundice-free survival between the two groups, the study concluded that iodine-125 brachytherapy is both effective and safe for this condition.